Wegovy vs Mounjaro: Mechanisms, Dosing & UK Availability
Wegovy 1mg vs Mounjaro: Core Mechanism Differences
When comparing Wegovy 1mg vs Mounjaro, the fundamental difference lies in how these prescription-only medicines work at the receptor level. Wegovy contains semaglutide, which specifically targets GLP-1 receptors to mimic your body's natural fullness hormone, reducing appetite and promoting satiety after smaller meals. Mounjaro uses tirzepatide, a dual agonist that activates both GIP and GLP-1 receptors, potentially offering a broader metabolic approach. Both treatments must be prescribed alongside a reduced-calorie diet and increased physical activity, but their different mechanisms mean your prescriber may favour one approach based on your individual medical history.
The practical implications of these mechanism differences become apparent in real-world use. Wegovy's targeted GLP-1 action has been extensively studied in the STEP trial programme, while Mounjaro's dual-receptor approach represents a newer therapeutic strategy. At EverydayMeds (GPhC #9012878), both options are available through the same streamlined prescription process, allowing your healthcare provider complete flexibility when weighing up Wegovy 1mg vs Mounjaro for your specific circumstances. Neither approach is inherently superior—the choice depends on your individual response, medical history, and clinical presentation.
Wegovy 1mg vs Mounjaro Pricing: Complete UK Cost Analysis
Understanding the cost comparison between Wegovy 1mg vs Mounjaro helps inform your treatment decision alongside clinical considerations. Our Wegovy 1mg pen costs £99.99 and represents weeks 9-12 of the mandatory dose escalation schedule, with new customers applying code FIRST40 at checkout for additional value. Mounjaro follows a different pricing structure due to its distinct dosing increments, starting at 2.5mg rather than following Wegovy's 0.25mg, 0.5mg, 1mg progression. For patients requiring consistent supply, our Consistency 1mg bundle provides two Wegovy 1mg pens for £209.99, ensuring uninterrupted treatment during this crucial mid-escalation phase.
When evaluating Wegovy 1mg vs Mounjaro across your entire treatment journey, consider that Wegovy follows a five-dose escalation (0.25mg to 2.4mg maintenance) while Mounjaro uses six dose levels (2.5mg to 15mg). This means different total costs and timeframes to reach maintenance dosing. Returning customers benefit from code DOSE25 applied at checkout across both treatment options. The Advance Duo bundle (1mg + 1.7mg) at £269.99 bridges seamlessly from your current 1mg dose towards the 1.7mg escalation, making financial planning more predictable than with alternative dosing schedules.
Clinical Evidence: Wegovy 1mg vs Mounjaro Trial Data
The clinical evidence supporting Wegovy centres around the landmark STEP trial programme, with STEP 1 demonstrating average weight reductions of approximately 15% at 68 weeks when patients took Wegovy alongside diet and exercise modifications (Wilding et al., NEJM, 2021). During the Wegovy 1mg phase specifically, patients typically experience established appetite regulation effects as they progress through weeks 9-12 of treatment. Mounjaro's evidence base derives from the SURMOUNT trials, though direct head-to-head comparisons between Wegovy 1mg vs Mounjaro aren't available due to different trial designs and patient populations.
When considering Wegovy 1mg vs Mounjaro, both treatments have demonstrated cardiovascular benefits in their respective trial programmes, with Wegovy's SELECT trial showing 20% reduction in major cardiovascular events. The 1mg dose represents a crucial midpoint where many patients notice significant appetite changes compared to the initial 0.25mg and 0.5mg doses. Individual responses vary considerably, and clinical trials represent average outcomes rather than assured individual results, which is why ongoing prescriber monitoring remains essential throughout your treatment journey.
How Wegovy 1mg Works in Your Weight Management Journey
Wegovy 1mg represents a pivotal point in your dose escalation where the GLP-1 receptor agonist effects become more pronounced than at lower doses. The medication works by mimicking incretin hormones that regulate blood sugar and appetite, specifically targeting brain centres responsible for hunger and satiety signals. At the 1mg level, most patients experience noticeable appetite reduction and feel satisfied with smaller meal portions, marking a significant step up from the initial 0.25mg and 0.5mg doses. This mechanism operates continuously throughout the week following your once-weekly injection, providing consistent appetite regulation rather than short-term effects. The gradual dose escalation to 1mg over 8 weeks allows your body to adapt while minimising potential side effects associated with starting at higher doses immediately.
EverydayMeds Ordering Process: Wegovy 1mg vs Mounjaro Access
Accessing either Wegovy 1mg or Mounjaro through EverydayMeds follows our streamlined three-step process designed for both treatments simultaneously. Complete our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals—the same assessment works whether you're considering Wegovy 1mg vs Mounjaro. Our qualified prescribers review every application within 3 working days (or 24 hours with express service), with the flexibility to recommend either treatment based on your individual circumstances rather than being limited to a single option. Once approved, your medication ships via next-day cold-chain delivery maintaining the 2-8°C temperature requirements essential for both treatments. This unified approach means you're not locked into a particular treatment choice until your prescriber has reviewed your full clinical picture.
Storage and Practical Considerations: Wegovy 1mg vs Mounjaro
Storage requirements reveal a practical advantage when comparing Wegovy 1mg vs Mounjaro for UK patients with varied lifestyles. Both medications require refrigeration at 2-8°C before first use, but Wegovy maintains potency for up to 6 weeks at room temperature (below 30°C) once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy particularly suitable for business travel, holidays, or situations where refrigeration access might be temporarily limited. The FlexTouch pen system used by Wegovy provides consistent, reliable dosing with clear visual confirmation of injection completion. Your 1mg dose represents weeks 9-12 of treatment before progressing to 1.7mg, giving you time to establish routine and confidence with the injection technique during this crucial escalation phase.
Dose Escalation: Wegovy 1mg vs Mounjaro Progression Patterns
The escalation pathway represents a key difference when evaluating Wegovy 1mg vs Mounjaro, with distinct implications for treatment duration and cost planning. Wegovy 1mg sits at the midpoint of a five-dose escalation (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) taking 16 weeks to reach maintenance dosing, while Mounjaro follows a six-dose progression with different starting points and intervals. This means your current Wegovy 1mg phase represents significant progress—you've completed 8 weeks of treatment and have 4 weeks at this dose before potentially moving to 1.7mg. The structured escalation cannot be rushed or abbreviated, making the midpoint 1mg dose a crucial consolidation period where appetite effects typically become well-established.
Understanding where Wegovy 1mg fits within your overall treatment timeline helps set appropriate expectations when comparing against Mounjaro's different escalation schedule. Many patients find the 1mg level provides meaningful appetite control while being better tolerated than jumping directly to higher doses, justifying the gradual progression approach. Your prescriber may recommend staying at 1mg longer than the standard 4 weeks if you're experiencing optimal effects with minimal side effects, which is why having both Wegovy and Mounjaro available through EverydayMeds provides maximum treatment flexibility.
Making Your Choice: Wegovy 1mg vs Mounjaro Decision Framework
Both Wegovy and Mounjaro are available from EverydayMeds with identical prescription processes, cold-chain delivery, and ongoing clinical support—your prescriber can help determine which aligns better with your individual circumstances. The choice between Wegovy 1mg vs Mounjaro often comes down to factors like your response to previous treatments, specific medical conditions, lifestyle considerations like travel requirements, and personal preference regarding injection frequency and dose escalation timelines. Our clinical team (GPhC #9012878) reviews every case individually rather than applying blanket recommendations, ensuring your prescription reflects your unique medical profile. Remember that you can complete our assessment covering both options, allowing your prescriber complete flexibility to recommend the most appropriate treatment based on their clinical judgement rather than being restricted to predetermined choices.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
